Overview

Gender

male

Tuygan Goker brings over 40 years of senior-level experience with F. Hoffman-La Roche, Ltd., to his role as a board member at Novimmune.

Most recently, he was the Director of Emerging Markets at Roche, where he was responsible for updating the company's wordlwide strategy.

Before that, he served as the Pharma Operational Head and Chairman of Roche's CEMAI Region, which included 110 countries in Central and Eastern Europe, the Middle East, Central Asia, Africa, and the Indian subcontinent.

During his career, Tuygan was primarily focused on building the Roche pharmaceutical business in emerging market countries, particularly Brazil, Russia, India, China, South Korea, Mexico and Turkey. He was responsible for founding numerous affiliates, joint ventures and partnerships, as well as negotiating and finalizing multiple manufacturing and commercial deals.

After his departure he established several pharma companies including TRPHARM & KONSINA focused on research and development, manufacturing and commercialization of specialty medicines across Europe and MENA(T) region. In addition he has held several senior roles in the boards of research and development companies through the commercialization of innovative medicine or M&A activity of the companies such as Novimmune S.A., LifeWatch, etc.

Tuygan received his pharmacy degree from Gazi University in Ankara, Turkey.